Balyasny Asset Management L.P.

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,297,935

+$785,098 QoQ

Shares Held

353,661

+111.7% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#66

of 344 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. RXRX ranks #118 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1			1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,297,935	353,661	+111.7%	Shares	Sole	2026-08-14
2026-03-31	$512,837	167,048	-75.0%	Shares	Sole	2026-05-15
2025-12-31	$2,732,831	668,174	+18.8%	Shares	Sole	2026-02-17
2025-09-30	$2,744,746	562,448	-13.8%	Shares	Sole	2025-11-14
2025-03-31	$3,452,486	652,644	+166.2%	Shares	Sole	2025-05-15
2024-06-30	$1,839,075	245,210	-69.4%	Shares	Sole	2024-08-14
2023-06-30	$5,978,390	800,320	+1094.8%	Shares	Sole	2023-08-14
2023-03-31	$446,796	66,986	-55.7%	Shares	Sole	2023-05-15
2022-12-31	$1,166,823	151,339	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.